Alzheimer's & Dementia: The Journal of the Alzheimer's Association
Volume 5, Issue 1 , Pages 12-17 , January 2009

Activity loss is associated with cognitive decline in age-related macular degeneration

  • Barry W. Rovner

      Affiliations

    • Departments of Psychiatry and Neurology, Jefferson Medical College, Philadelphia, PA, USA
    • Corresponding Author InformationCorresponding author. Tel.: 215-503-1254; Fax: 215-503-1992
    • ,
  • Robin J. Casten

      Affiliations

    • Department of Psychiatry and Human Behavior, Jefferson Medical College, Philadelphia, PA, USA
    • ,
  • Benjamin E. Leiby

      Affiliations

    • Division of Biostatistics, Department of Pharmacology and Experimental Therapeutics, Jefferson Medical College, Philadelphia, PA, USA
    • ,
  • William S. Tasman

      Affiliations

    • Wills Eye Institute, Department of Ophthalmology, Jefferson Medical College, Philadelphia, PA, USA

References 

  1. Verghese J, Lipton RB, Katz MJ, Hall CB, Derby CA, et al. Leisure activities and the risk of dementia in the elderly. N Engl J Med. 2003;348:2508–2516
  2. Wilson RS, Mendes de Leon CF, Barnes LL, Schneider JA, Bienias JL, et al. Participation in cognitively stimulating activities and risk of incident Alzheimer's disease. JAMA. 2002;287:742–748
  3. Wang JYJ, Zhou HD, Li J, Zhang M, Deng J, et al. Leisure activity and the risk of cognitive impairment: the Chong Qing Aging Study. Neurology. 2006;66:911–913
  4. Sturman MT, Morris MC, Mendes de Leon CF, Bienias J, Wilson RS, et al. Physical activity, cognitive activity, and cognitive decline in a biracial community population. Arch Neurol. 2005;62:1750–1754
  5. Rockwood K, Middleton L. Physical activity and the maintenance of cognitive function. Alzheimer's and Dementia. 2007;3(Suppl 1):S38–S44
  6. Hendrie HC, Albert MS, Butters MA, Gao S, Knopman DS, et al. The NIH Cognitive and Emotional Health Project: report of the critical evaluations study committee. Alzheimer's and Dementia. 2006;2:12–32
  7. Bennett DA, Schneider JA, Tang Y, Arnold SE, Wilson RS. The effect of social networks on the relation between Alzheimer's disease pathology and level of cognitive function in older people: a longitudinal cohort study. Lancet Neurol. 2006;5:406–412
  8. Bassuk S, Glass TA, Berkman LF. Social disengagement and incident cognitive decline in community-dwelling elderly persons. Ann Intern Med. 1999;131:165–173
  9. Seeman TE, Lusignolo TM, Albert M, Berkman L. Social relationships, social support, and patterns of cognitive aging in healthy, high-functioning older adults: MacArthur Studies of Successful Aging. Health Psychol. 2001;20:243–255
  10. The Eye Diseases Prevalence Research Group. Causes and prevalence of visual impairment among adults in the United States. Arch Ophthalmol 2004;122:477–85.
  11. Williams RA, Brody BL, Thomas RG, Kaplan RM, Brown SI. The psychosocial impact of macular degeneration. Arch Ophthalmol. 1998;116:514–520
  12. Stelmack J. Quality of life of low-vision patients and outcomes of low-vision rehabilitation. Optom Vis Sci. 2001;78:335–342
  13. Mangione CM, Gutierrez PR, Lowe G, Orav EJ, Seddon JM. Influence of age-related maculopathy on visual functioning in health-related quality of life. Am J Ophthalmol. 1999;128:45–53
  14. Chia EM, Mitchell P, Rochthina E, Foran S, Golding M, Jie JW. Association between vision and hearing impairments and their combined effects on quality of life. Arch Ophthalmol. 2006;124:1465–1470
  15. Klaver CCW, Ott A, Hofman A, Assink JM, Bereteler MMB, et al. Is age-related maculopathy associated with Alzheimer's disease?: the Rotterdam Study. Am J Epidemiol. 1999;150:963–968
  16. Wyoshida T, Ohno-Matsui K, Ichinose S, Sato T, Iwata N, et al. The potential role of amyloid beta in the pathogenesis of age-related macular degeneration. J Clin Invest. 2005;115:2793–2800
  17. Lindenberger U, Baltes PB. Sensory functioning and intelligence in old age: a strong connection. Psychol Aging. 1994;9:339–355
  18. Rovner B, Casten R, Hegel M, Leiby B, Tasman W. Preventing depression in age-related macular degeneration. Arch Gen Psychiatry 2007:64:886–92.
  19. Folstein M, Folstein S, McHugh P. “Mini-Mental State”: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189–198
  20. Massof RW, Fletcher DC. Evaluation of the NEI visual functioning questionnaire as an interval measure of visual ability in low vision. Vision Res. 2001;41:397–413
  21. D'Zurilla TJ. Problem-solving therapy: a social competence approach to clinical intervention. New York: Springer Pub; 2000;95–150
  22. Rubin GS, Bandeen Roche K, Prasada-Rao P, Fried LP. Visual impairment and disability in older adults. Optom Vis Sci. 1994;12:750–760
  23. Holladay JT, Prager TC. Mean visual acuity. Am J Ophthalmol. 1991;111:372–374
  24. Von Korff M, Wagner EH, Saunders K. A chronic disease score from automated pharmacy data. J Clin Epidemiol. 1992;45:197–203
  25. Clark DO, Von Korff M, Saunders K, Baluch WM, Simon GE. A chronic disease score with empirically derived weights. Med Care. 1995;33:783–795
  26. Parmelee PA, Katz IR, Lawton MP. The relation of pain to depression among institutionalized aged. J Gerontol. 1991;46:P15–P21
  27. Williams JB. A structured interview guide for the Hamilton Depression Rating Scale. Arch Gen Psychiatry 1988;45:742–7.
  28. Jorm AF. The Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE): a review. Int Psychogeriatr. 2004;16:275–293
  29. Jorm AF. A short form of the Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE): development and cross-validation. Psychol Med. 1994;24:145–153
  30. Carter RE, Lipsitz SR, Tilley BC. “Quasi-likelihood estimation for relative risk regression models.”. Biostatistics. 2005;6:39–44
  31. Mungas D, Reed BR, Ellis WG, Jagust W. The effects of aging on rate of progression of Alzheimer's disease and dementia with associated cerebrovascular disease. Arch Neurol. 2001;58:1243–1247
  32. Bäckman L, Jones S, Small BJ, Agüero-Torres H, Fratiglioni L. Rate of cognitive decline in preclinical Alzheimer's disease: the role of comorbidity. J Gerontol Psychol Social Sci. 2003;58:228–236
  33. Breitner JCS. Dementia-epidemiological considerations, nomenclature, and a tacit consensus definition. J Geriatr Psychiatry Neurol. 2006;19:129–136
  34. Crews JE, Campbell VA. Vision impairment and hearing loss among community-dwelling older Americans: implications for health and functioning. Am J Public Health. 2004;94:823–829
  35. Reyes-Ortiz CA, Kuo WS, DiNuzzo AR, Ray LA, Raji MA, et al. Near vision impairment predicts cognitive decline: data from the Hispanic Established Populations for Epidemiologic Studies of the Elderly. J Am Geriatr Soc. 2005;53:681–686
  36. Age-Related Eye Disease Study Research Group. Cognitive impairment in the age-related eye disease study. AREDS report no. 16. Arch Ophthalmol 2006;124:537–43.
  37. Gandy S. The role of cerebral amyloid beta accumulation in common forms of Alzheimer's disease. J Clin Invest. 2005;115:1–9
  38. Hinton DR, Sadun AA, Blanks JC, Miller CA. Optic-nerve degeneration in Alzheimer's disease. N Engl J Med. 1986;315:485–487
  39. Schmidt S, Klaver CCW, Saunders AM, Postel EA, DeLaPaz MA, et al. A pooled case-controlled study of the apolipoprotein E (APOE) gene in age-related maculopathy. Ophthalmic Genet. 2002;23:209–223
  40. Bird TD. Genetic factors in Alzheimer's disease. N Engl J Med. 2005;352:862–864
  41. Burke D, Hickie I, Breakspear M, Goatz J. Possibilities for the prevention and treatment of cognitive impairment and dementia. Br J Psychiatry. 2007;190:371–372
  42. Lee BK, Glass TA, McAtee MJ, Wand GS, Bandeen-Roche K, et al. Associations of salivary cortisol with cognitive function in the Baltimore Memory Study. Arch Gen Psychiatry. 2007;64:810–818

PII: S1552-5260(08)02834-3

doi: 10.1016/j.jalz.2008.06.001

Alzheimer's & Dementia: The Journal of the Alzheimer's Association
Volume 5, Issue 1 , Pages 12-17 , January 2009

Article Tools

* Image Usage & Resolution